GlaxoSmithKline Pharmaceuticals informs about certificate

07 Oct 2021 Evaluate

In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, GlaxoSmithKline Pharmaceuticals has informed that it enclosed a copy of the Certificate received from Kfintech Technologies, the Registrar and share Transfer Agent of the Company, for the quarter ended 30th September 2021.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2570.00 -54.85 (-2.09%)
27-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.10
Dr. Reddys Lab 1287.20
Cipla 1347.65
Zydus Lifesciences 922.50
Lupin 2301.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×